Next Generation AAV Vectors

At rAAVen Therapeutics, we combine rigorous science with curiosity-driven research to enable the next generation of gene therapies. Leveraging deep expertise in AAV biology, we design and engineer novel capsids to address a wide range of disorders across diverse tissues and organs. Using state-of-the-art methodologies in molecular cloning, high-throughput AAV variant production, and next-generation sequencing, we create viral vectors optimized for precision delivery to defined cell populations and tailored functional properties.